A Comprehensive Oncological Biomarker Framework Guiding Precision Medicine
Biomolecules · 10.09.2025 · 15 (9) · 1304
DOI: 10.3390/biom15091304 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, online erschienen am 10.09.2025. Verfasst von Reza Bayat Mokhtari und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, 265 Elm and Carlton Streets, Buffalo, NY 14263, USA. Hauptthemen laut MEDLINE: Precision Medicine, Biomarkers, Tumor, Neoplasms. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 295 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Department of Pharmacology and Therapeutics at Roswell Park Comprehensive Cancer Center.
Abstract (Originalsprache)
Cancer remains a major cause of mortality worldwide, driving ongoing innovation in therapeutic strategies. Immunotherapy has transformed cancer care by leveraging the immune system to target tumors, but its effectiveness is limited by tumor heterogeneity, immune resistance, and unpredictable toxicities. Moreover, the absence of robust biomarkers to predict therapeutic response and manage adverse effects remains a significant challenge. Recent advances in biomarker discovery, including liquid biopsy technologies and gut microbiota profiling, are enhancing the precision of immunotherapy and enabling more personalized cancer management. Here, we present a Comprehensive Oncological Biomarker Framework that integrates genetic and molecular testing, imaging, histopathology, multi-omics, and liquid biopsy to generate a molecular fingerprint for each patient. This holistic approach supports individualized diagnosis, prognosis, treatment selection, and response monitoring. Incorporating emerging biomarkers, such as microbiome signatures, further refines patient stratification, guiding the optimization of therapy. By uniting molecular insights with clinical and social factors, this framework aims to address tumor heterogeneity and immune evasion, ultimately improving patient outcomes through precision oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, 265 Elm and Carlton Streets, Buffalo, NY 14263, USA.
- Program of Developmental Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
- Department of Biomedical and Molecular Sciences, Queen's University, Kingston, ON K7L 3N6, Canada.
- Allergy and Clinical Immunology Division, Rady Children's Hospital, University of California, San Diego, CA 92123, USA.
- Hematology and Oncology Division, Charleston Area Medical Center, Charleston, WV 25304, USA.
- Laboratory of Oncology, Fondazione IRCCS Casa Sollievo della Sofferenza, Viale Cappuccini, 71013 San Giovanni Rotondo, Italy.
ORCID-Profile: Faezeh Shekari, Roya Ghafoury, Lucia Anna Muscarella, Myron R Szewczuk, Sayan Chakraborty
Förderung
- Department of Pharmacology and Therapeutics at Roswell Park Comprehensive Cancer Center
Zitieren
APA
Mokhtari, R. B., Sambi, M., Shekari, F., Satari, K., Ghafoury, R., Ashayeri, N., Eversole, P., Baluch, N., Harless, W. W., Muscarella, L. A., Yeger, H., Das, B., Szewczuk, M. R., & Chakraborty, S. (2025). A Comprehensive Oncological Biomarker Framework Guiding Precision Medicine. Biomolecules, 15(9), 1304. https://doi.org/10.3390/biom15091304
Vancouver
Mokhtari RB, Sambi M, Shekari F, Satari K, Ghafoury R, Ashayeri N, et al. A Comprehensive Oncological Biomarker Framework Guiding Precision Medicine. Biomolecules. 2025;15(9):1304. doi:10.3390/biom15091304
BibTeX
@article{Mokhtari2025,
author = {Mokhtari, Reza Bayat and Sambi, Manpreet and Shekari, Faezeh and Satari, Kosar and Ghafoury, Roya and Ashayeri, Neda and Eversole, Paige and Baluch, Narges and Harless, William W and Muscarella, Lucia Anna and Yeger, Herman and Das, Bikul and Szewczuk, Myron R and Chakraborty, Sayan},
title = {A Comprehensive Oncological Biomarker Framework Guiding Precision Medicine},
journal = {Biomolecules},
year = {2025},
volume = {15},
number = {9},
pages = {1304},
doi = {10.3390/biom15091304}
}
EUVIMED